Thomas Michler
Munich, BY 80539, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Long-term antigen reduction does not achieve durable HBV control in mice but enhances therapeutic vaccine efficacy.
Journal: JHEP reports : innovation in hepatology
Published: March 21, 2026
Multifactorial Analysis Identifies Conditions for Robust HCoV-OC43 Replication in Primary Human Bronchial Epithelial Cells Cultured at Air-Liquid Interface.
Journal: Cells
Published: December 05, 2025
Implementation and User Satisfaction of a Comprehensive Telemedicine Approach for SARS-CoV-2 Self-Sampling: Monocentric, Prospective, Interventional, Open-Label, Controlled, Two-Arm Feasibility Study.
Journal: JMIR formative research
Published: February 21, 2024
The lack of HBsAg secretion does neither facilitate induction of antiviral T cell responses nor Hepatitis B Virus clearance in mice.
Journal: Antiviral research
Published: January 31, 2024
Viral genome sequencing to decipher in-hospital SARS-CoV-2 transmission events.
Journal: Scientific reports
Published: August 30, 2023
Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 15, 2022
Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread.
Journal: Nucleic acids research
Published: November 25, 2020
Author Correction: Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models.
Journal: Scientific reports
Published: November 04, 2020
siRNA Therapeutics against Respiratory Viral Infections-What Have We Learned for Potential COVID-19 Therapies?
Journal: Advanced healthcare materials
Published: September 15, 2020
Last Updated: 09/26/2026